Sign up to save your podcasts
Or
Share Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
CME credits: 0.25
Valid until: 27-10-2022
Claim your CME credit at https://reachmd.com/programs/cme/making-case-iron-replacement-therapy-hfref-clinical-and-pharmacoeconomic-impact/12990/
Assessing iron deficiency is a crucial aspect of heart failure (HF) that warrants close clinical consideration, especially because it remains underdiagnosed and undertreated.
In this expert panel discussion, we examine data from AFFIRM-HF supporting the importance of correcting iron deficiency in patients with HF. Find out how treating iron deficiency can change the natural history of heart disease, lead to cost savings, and improve patients’ lives.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 27-10-2022
Claim your CME credit at https://reachmd.com/programs/cme/making-case-iron-replacement-therapy-hfref-clinical-and-pharmacoeconomic-impact/12990/
Assessing iron deficiency is a crucial aspect of heart failure (HF) that warrants close clinical consideration, especially because it remains underdiagnosed and undertreated.
In this expert panel discussion, we examine data from AFFIRM-HF supporting the importance of correcting iron deficiency in patients with HF. Find out how treating iron deficiency can change the natural history of heart disease, lead to cost savings, and improve patients’ lives.